A study to investigate the effect of Lepodisiran, a subcutaneous injection, with hopes to reduce the risk of major cardiovascular events (heart attacks, strokes, needing stents, bypass surgery) by decreasing lipoprotein a values.
Enrollment
Open
Patient Commitment Duration
4-5 years
Number of visits in study
24 (this includes an extended maintenance period)
Patient Compensation
Varies with each completed visit ranged from $28-$112
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
A 48-week, phase 3 study to investigate the efficacy and safety of Retatrutide compared with placebo in adult participants with type II diabetes and inadequate glycemic control with diet and exercise alone.
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
Elagolix in combination with combined oral contraceptives in women with moderate-to-severe endometriosis pain.
Enrollment
Open
Patient Commitment Duration
45 months
Number of visits in study
14 onsite visits, 10 telephone visits
Patient Compensation
$25-100 payment varies per visit
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
The purpose of this study is to compare the effects of an experimental drug, Milvexian, to the comparator drug, Apixaban (Eliquis) to determine if it is safe and useful in reducing the risk of stroke and blood clots outside the brain in participants with atrial fibrillation.
Enrollment
Open
Patient Commitment Duration
3.5-4 years
Number of visits in study
Up to 15 visits
Patient Compensation
$100 per visit
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
A clinical trial in healthy volunteers to study the safety, tolerability, and immune responses after vaccination with an investigational vaccine designed to prevent genital herpes lesions.
Enrollment
Open
Patient Commitment Duration
18 months
Number of visits in study
12 scheduled in person visits, 1 phone call
Patient Compensation
$205 for the 12 scheduled visits. $130 for phone call visit and any unscheduled visits.
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
A 12-month study providing FDA approved oral testosterone replacement therapy JATENZO in men diagnosed with hypogonadism to assess adrenal insufficiency.
Enrollment
Open
Patient Commitment Duration
12 months
Number of visits in study
13
Patient Compensation
$53 per visit
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
